EFFECT OF PREOPERATIVE ANTICOAGULANT TREATMENT ON ACTIVATED COAGULATION TIME AND HEPARIN LEVELS DURING NORMOTHERMIC CARDIOPULMONARY BYPASS (CPB)

被引：0
|
作者：
LONGROIS, D
GONCALVES, O
DEPOIX, JP
ENGUERAND, D
PHILIP, Y
MONTRAVERS, P
CHATEL, D
HVASS, U
DESMONTS, JM
机构：
[1] HOP BICHAT,DEPT ANESTHESIA,PARIS,FRANCE
[2] HOP BICHAT,DEPT CARDIOVASC SURG,PARIS,FRANCE
来源：
BRITISH JOURNAL OF ANAESTHESIA | 1995年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
引用
收藏
页码：31 / 31
页数：1
相关论文
共 50 条
  • [41] INVITRO EFFECT OF FRESH-FROZEN PLASMA ON THE ACTIVATED COAGULATION TIME IN PATIENTS UNDERGOING CARDIOPULMONARY BYPASS
    BARNETTE, RE
    SHUPAK, RC
    PONTIUS, J
    RAO, AK
    ANESTHESIA AND ANALGESIA, 1988, 67 (01): : 57 - 60
  • [42] Maintenance of blood heparin concentration rather than activated clotting time better preserves the coagulation system in hypothermic cardiopulmonary bypass
    Shirota, K
    Watanabe, T
    Takagi, Y
    Ohara, Y
    Usui, A
    Yasuura, K
    ARTIFICIAL ORGANS, 2000, 24 (01) : 49 - 56
  • [43] Effect of cardiopulmonary bypass and heparin on plasma levels of Lp(a) and apo(a) fragments
    Mooser, V
    Tinguely, F
    Fontana, P
    Lenain, V
    Vaglio, M
    Ruchat, P
    von Segesser, LK
    Marcovina, SM
    Markert, M
    Darioli, R
    Nicod, P
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (04) : 1060 - 1065
  • [44] Effect of perfusion pressure on cerebral blood flow during normothermic cardiopulmonary bypass
    Newman, MF
    Croughwell, ND
    White, WD
    Lowry, E
    Baldwin, BI
    Clements, FM
    Davis, RD
    Jones, RH
    Amory, DW
    Reves, JG
    CIRCULATION, 1996, 94 (09) : 353 - 357
  • [45] Effect of temperature on leukocyte activation during cardiopulmonary bypass (CPB) and postoperative organ damage
    M Qing
    M-C Seghaye
    JF Vazquez-Jimenez
    RG Grabitz
    B Klosterhalfen
    M Sigler
    BJ Messmer
    G von Bernuth
    Critical Care, 3 (Suppl 2):
  • [46] Effect of temperature on critical cerebral perfusion pressure in dogs during cardiopulmonary bypass (CPB).
    Sungurtekin, H
    Dickerman, DL
    Orszulak, TA
    Cook, DJ
    ANESTHESIA AND ANALGESIA, 1999, 88 (04): : U96 - U96
  • [47] Heparin concentrations in neonates during cardiopulmonary bypass as measured by the activated clotting time and anti-Xa assay
    Keogh, J.
    Davidson, S. J.
    Machin, M.
    Hall, J.
    Kelleher, A. A.
    ANAESTHESIA, 2009, 64 (12) : 1388 - 1389
  • [48] The activated clotting time loading dose response ratio (ACTLORR) as an indicator of heparin demand during cardiopulmonary bypass
    Reece, Ian J.
    Linley, Gerrard
    Al Tareif, Habib
    DeVroege, Rollie
    Tolia, Jitesh
    Sheth, Jayesh
    PERFUSION-UK, 1996, 11 (02): : 125 - 130
  • [49] CORRELATION OF PLASMA HEPARIN LEVELS WITH AUTOMATED CLOTTING TIMES DURING CARDIOPULMONARY BYPASS
    BUTT, RW
    LEBLANC, P
    DERMODY, L
    CANADIAN JOURNAL OF MEDICAL TECHNOLOGY, 1980, 42 (03): : 83 - 84
  • [50] Decreased concentration of antithrombin after preoperative therapeutic heparin does not cause heparin resistance during cardiopulmonary bypass
    Linden, MD
    Schneider, M
    Baker, S
    Erber, WN
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2004, 18 (02) : 131 - 135
12345